| Title: | Epilepsy and long-term risk of arrhythmias |
| Journal: | European Heart Journal |
| Published: | 21 Aug 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37602368/ |
| DOI: | https://doi.org/10.1093/eurheartj/ehad523 |
| URL: | https://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehad523/51176730/ehad523.pdf |
| Citations: | 18 (18 in last 2 years) as of 8 Aug 2024 |
Publication 7687
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND AND AIMS: Previous evidence has mainly supported transient changes in cardiac function during interictal or peri-ictal phases in people with epilepsy, but the long-term risk of cardiac arrhythmias is poorly described. This study aimed to assess the long-term association of epilepsy with cardiac arrhythmias, considering the potential role of genetic predisposition and antiseizure medications (ASMs) in any associations observed.</p>
METHODS: This population-based study evaluated UK Biobank data for individuals recruited between 2006 and 2010. Cox proportional hazards models and competing risk models were used to examine the association of epilepsy history with the long-term incidence risk of cardiac arrhythmias and arrhythmias subtypes. Polygenic risk scores (PRS) were calculated to investigate the effect of genetic susceptibility. The role of ASMs was also evaluated by integrating observational and drug target Mendelian randomization (MR) evidence.</p>
RESULTS: The study included 329 432 individuals, including 2699 people with epilepsy. Compared with those without epilepsy, people with epilepsy experienced an increased risk of all cardiac arrhythmias [hazard ratio (HR) 1.36, 95% confidence interval (CI) 1.21-1.53], atrial fibrillation (HR 1.26, 95% CI 1.08-1.46), and other cardiac arrhythmias (HR 1.56, 95% CI 1.34-1.81). The associations were not modified by genetic predisposition as indicated by PRS. Competing and sensitivity analyses corroborated these results. Individuals with epilepsy using ASMs, especially carbamazepine and valproic acid, were at a higher risk for cardiac arrhythmias. This observation was further supported by drug target MR results (PSMR < .05 and PHEIDI > .05).</p>
CONCLUSION: This study revealed the higher risk of cardiac arrhythmias persists long term in people with epilepsy, especially among those using carbamazepine and valproic acid. These findings highlight the need for regular heart rhythm monitoring and management in people with epilepsy in order to reduce the risk of further cardiovascular complications.</p>
12 Authors
- Jie Wang
- Peiyuan Huang
- Qingwei Yu
- Jun Lu
- Pinbo Liu
- Yiping Yang
- Zeying Feng
- Jingjing Cai
- Guoping Yang
- Hong Yuan
- Haibo Tang
- Yao Lu
1 Application
| Application ID | Title |
|---|---|
| 75283 | Modifiable pathways in sex-specific arterial stiffness: Mendelian randomization analysis |
Enabling scientific discoveries that improve human health